MedPath

Effects of fingolimod on advanced brain measures and clinical measures in multiple sclerosis

Conditions
multiple sclerosis, functional magnetic resonance imaging, cognition, functional brain adaptationmultiple sclerose, functionele MRI, cognitie, functionele brein adaptatie
Registration Number
NL-OMON24446
Lead Sponsor
VU University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

Subjects should be between 18 and 65 years of age

- Subjects should meet the safety criteria to undergo MRI examination

Exclusion Criteria

- Presence or history of psychiatric or neurological disease (for patients: neurological disease other than MS)

- Presence or history of drug abuse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Improved neuropsychological test performance<br /><br>- Changed functional MRI/connectivity<br /><br>- Improved cognitive well-being
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath